-
Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)
(PAR-22-104)
John E. Fogarty International Center
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Dental and Craniofacial Research
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Office of Disease Prevention
Application Receipt Date(s): Multiple dates, see announcement.
-
Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
(PAR-22-107)
National Human Genome Research Institute
National Institute of Mental Health
Application Receipt Date(s): November 6, 2022
-
International Bioethics Research Training Program (D43 Clinical Trial Optional)
(PAR-22-116)
John E. Fogarty International Center
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
Application Receipt Date(s): June 6, 2024
-
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
(PAR-22-118)
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
Application Receipt Date(s): June 6, 2024
-
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
(PAR-22-123)
National Institute of Biomedical Imaging and Bioengineering
National Institute on Aging
National Cancer Institute
National Eye Institute
Application Receipt Date(s): January 7, 2025
-
NIA Program Project Applications (P01 Clinical Trial Optional)
(PAR-22-130)
National Institute on Aging
Application Receipt Date(s): September 7, 2025
-
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
(PAR-22-135)
National Eye Institute
Application Receipt Date(s): May 7, 2025
-
Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)
(RFA-AI-22-019)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): April 19, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)
(RFA-AI-22-022)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): August 3, 2022
-
Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)
(RFA-CA-22-015)
National Cancer Institute
Application Receipt Date(s): July 6, 2022
-
CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect (P50) (Clinical Trial Optional)
(RFA-HD-23-007)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): July 27, 2022
-
Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed)
(RFA-MH-22-200)
National Institute of Mental Health
Application Receipt Date(s): October 18, 2022
-
Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
(RFA-OD-22-003)
Office of Disease Prevention
National Institute on Drug Abuse
Application Receipt Date(s): July 14, 2022
-
Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
(RFA-OD-22-004)
Office of Disease Prevention
National Cancer Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Heart, Lung, and Blood Institute
Application Receipt Date(s): July 14, 2022